TORONTO, ON /ACCESS Newswire/ July 29, 2026 /Blueberries Medical Corp. (CSE:BBM)(OTCID:BBRRF)(FRA:1OA) (the "Company" or "Blueberries"), a consumer science company focused on health, wellness and longevity, and a licensed producer of both psychoactive and non-psychoactive cannabis derivatives in Colombia, is pleased to announce a non-brokered private placement consisting of the sale of 84,615,385 common shares ("Common Shares") at a price of C$0.013 per Common Share for aggregate gross proceeds of approximately C$1.1 million (or approximately US$781,000) (the "Offering"). The net proceeds from the sale of the Common Shares are expected to fund and...